Advertisement

Topics

Tissue Regenix Group plc Company Profile

15:56 EDT 25th June 2019 | BioPortfolio

Tissue Regenix is a leading medical devices company in the field of regenerative medicine. Tissue Regenix was formed in 2006 when it was spun-out from the University of Leeds, UK. The company's patented decellularisation ('dCELL®') technology removes DNA and other cellular material from animal and human soft tissue leaving an acellular tissue scaffold which is not rejected by the patient's body and can then be used to repair diseased or worn out body parts. Current applications address many critical clinical needs such as sports medicine, heart valve replacement and wound care.


News Articles [1203 Associated News Articles listed on BioPortfolio]

Tissue Regenix eyes US expansion

UK-based Tissue Regenix is looking to expand in the US through the launch of its OrthoPure HT decellularized human tendon for -More- 

Tissue Regenix continues regeneration as its targets breaking even by 2020

Earlier this month, Tissue Regenix reported full-year results showing revenues more than doubled last year to £11.6mln, up from £5.2mln a year earlier

Tissue Regenix continues regeneration as it targets breaking even by 2020

Earlier this month, Tissue Regenix reported full-year results showing revenues more than doubled last year to £11.6mln, up from £5.2mln a year earlier

Tissue Regenix flush with cash after doubling revenues in 2018

Bosses expect to move another step closer towards profitability in the year ahead, before breaking even in 2020 – a long-term target for the group

Tissue Regenix secures additional coverage for DermaPure from a US Group Purchasing Organization

The AIM-listed firm said the additional coverage will open up access to a further 1,500 hospitals and 32,500 alternative care providers, primarily in the South Eastern region of the US

Tissue Regenix boss to return to full-time duties in June

Steve Couldwell has been out of action so far this year while he undergoes medical treatment

Tissue Regenix’s Decellularized Human Dermis Product, DermaPure, Demonstrated Substantial Clinical and Cost Benefits in Case Series Presented at Cleveland Clinic Accredited VEITH Symposium

The results from a six patient case series indicate a reduction in the number of procedures required, the time taken to heal, and the overall economic cost of healing T...

Tissue Regenix’s Decellularized Human Dermis Product, DermaPure, Demonstrated Substantial ...

The results from a six patient case series indicate a reduction in the number of procedures required, the time taken to heal, and the overall economic cost of healing Read more...

Drugs and Medications [0 Results]

None

PubMed Articles [3482 Associated PubMed Articles listed on BioPortfolio]

Experimental infection in mice with Erwinia persicina.

Erwinia persicinus (E. persicina) is a plant pathogenic bacterial species that was previously isolated from a case of human infection. This study aimed to create an experimental infection protocol for...

A Proposal of Pseudo-periosteum Classification After GBR by Means of Titanium-Reinforced d-PTFE Membranes or Titanium Meshes Plus Cross-Linked Collagen Membranes.

After guided bone regeneration (GBR) with different devices, a layer of connective tissue called pseudo-periosteum can be observed above the newly formed bone. The aim of this study is to evaluate the...

Research and application of magnetic resonance coordinate transformation method for brain control technology of carp robots.

To solve the problem of precise positioning of carp brain tissue coordinates, it is proposed in this paper for a method for transforming the coordinates of magnetic resonance imaging of carp brain tis...

Establishment of rat model of cardiorenal syndrome by transabdominal subtotal nephrectomy.

To evaluate the changes of rat renal function and cardiac function after transabdominal subtotal nephrectomy (STNx) and provide an ideal animal model for the study of chronic kidney disease (CKD) and ...

The expression changes and correlation analysis of high mobility group box-1 and tissue factor in the serum of rats with sepsis.

To investigate the expression changes of high mobility group box-1 (HMGB-1) and tissue factor (TF) and their correlation in the serum of sepsis rat models.

Clinical Trials [7765 Associated Clinical Trials listed on BioPortfolio]

Impact of Soft Tissue Grafts on Tissue Alterations After Immediate Tooth Replacement

This study evaluates the impact of soft tissue grafts on soft tissue recession following immediate implant, provisional and bone graft placement in compromised sockets. One third of the pa...

Pontic Site Development With Connective Tissue Graft Using Modified Pouch Technique Versus Pouch Technique

The study will be formed on two groups : the control group and the test group For both groups base line impressions will be taken before the surgery and a free gingival graft will be harve...

Peri-implant Mucosal Recession Evaluation Following Soft Tissue Augmentation Using CTG Around Immediate Dental Implants vs Immediate Dental Implants Alone in the Esthetic Zone.

Aim of current study to evaluate connective tissue graft combined with immediate implant placement as an innovative option for less facial gingival tissue recession, less pocket depth and ...

The Effects of Connective Tissue Manipulation in Primary Dysmenorrhea

Brief Summary: The aim of the present study is to investigate the efficacy of connective tissue massage in patients with primary dysmenorrhea. The present study is designed as a randomized...

Sensory Reconstruction of the Digits

A retrospective study is conducted with 151 patients who has a soft tissue defect of digit treated with the sensate flaps from February 2005 to March 2014. Based on the different regions o...

Companies [2284 Associated Companies listed on BioPortfolio]

Tissue Regenix Group plc

Tissue Regenix is a leading medical devices company in the field of regenerative medicine. Tissue Regenix was formed in 2006 when it was spun-out from the University of Leeds, UK....

Tissue Regenix

Tissue Regenix is a leading medical devices company in the field of regenerative medicine. The company's patented decellularisation ('dCELL®') Technology removes DNA and other ...

Cascades Tissue Group

Cascades Tissue Group, a division of Cascades, ULC, is the fourth largest manufacturer of tissue paper in North America. Founded in 1964, Cascades produces, converts and markets p...

PPA Research Group

PPA Research Group is a biotechnology company dedicated to providing global life sciences with the highest quality hematologic tissues and cells that enable drug discovery, stem c...

Bio-Tissue, Inc.

As the industry leader, Bio-Tissue is committed to providing the highest quality and safest bioengineered tissue & cell-based amnion products to ophthalmologists worldwide

More Information about "Tissue Regenix Group plc" on BioPortfolio

We have published hundreds of Tissue Regenix Group plc news stories on BioPortfolio along with dozens of Tissue Regenix Group plc Clinical Trials and PubMed Articles about Tissue Regenix Group plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tissue Regenix Group plc Companies in our database. You can also find out about relevant Tissue Regenix Group plc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record